Methodological and regulatory considerations for causal AI in drug development
npj Digital Medicine, Published online: 27 February 2026; doi:10.1038/s41746-026-02477-wMethodological and regulatory considerations for causal AI in drug development
npj Digital Medicine, Published online: 27 February 2026; doi:10.1038/s41746-026-02477-wMethodological and regulatory considerations for causal AI in drug development
npj Digital Medicine, Published online: 27 February 2026; doi:10.1038/s41746-026-02474-zDeep learning for fast screening and localization of spinal dural arteriovenous fistulas to enhance clinical workflow
npj Digital Medicine, Published online: 27 February 2026; doi:10.1038/s41746-026-02468-xMachine learning–guided Huanglian Jiedu decoction targets STING in periodontitis-induced Alzheimer’s Disease
npj Digital Medicine, Published online: 27 February 2026; doi:10.1038/s41746-026-02433-8Advancing medical AI through benchmarking and competition for specialty triage
npj Digital Medicine, Published online: 27 February 2026; doi:10.1038/s41746-026-02473-0SynthEHR-eviction: enhancing eviction SDoH detection with LLM-augmented synthetic EHR data
npj Digital Medicine, Published online: 27 February 2026; doi:10.1038/s41746-026-02492-xA scalable framework for evaluating health language models
Knight Therapeutics has announced the regulatory submission of axatilimab in Brazil to treat chronic graft-versus-host disease (cGvHD). The post Knight Therapeutics advances chronic GvHD expansion strategy appeared first on Medical Device Network.
GE HealthCare has launched its next-generation of LOGIQ ultrasound systems, designed to enhance clinical imaging and expedite workflows. The post GE HealthCare launches general imaging ultrasound systems appeared first on Medical Device Network.
Quantum Surgical has acquired NeuWave Medical, supporting its strategy to broaden access to robotic-assisted tumour ablation treatments for reducing cancer mortality. The post Quantum acquires NeuWave Medical to enhance tumour ablation treatments appeared first on Medical Device Network.
npj Digital Medicine, Published online: 26 February 2026; doi:10.1038/s41746-026-02445-4A device-invariant multi-modal learning framework for respiratory disease classification
npj Digital Medicine, Published online: 26 February 2026; doi:10.1038/s41746-026-02494-9Vision-Enabled AI scribes reduce omissions in clinical conversations: evidence from simulated medication histories
npj Digital Medicine, Published online: 26 February 2026; doi:10.1038/s41746-026-02469-wMulti night digital assessment of sleep disordered breathing is associated with accelerated vascular aging
TECLens has commenced the first-in-human clinical trial assessing its qCXL technology for non-invasive refractive vision correction, administering treatment to the initial patient. The post TECLens begins first-in-human trial for qCXL vision correction technology appeared first on Medical Device Network.
The proposed IPO could see MiniMed offer 28m shares as the company looks to reach profitability independently of Medtronic. The post Medtronic’s diabetes business MiniMed looks for $784m in US IPO appeared first on Medical Device Network.
Stryker has launched Synchfix EVT, a flexible syndesmotic fixation device intended to simplify surgical procedures and support ankle stabilisation in patients with syndesmotic disruptions. The post Stryker unveils Synchfix EVT for flexible syndesmotic ankle fixation appeared first on Medical Device Network.
npj Digital Medicine, Published online: 25 February 2026; doi:10.1038/s41746-026-02488-7Imaging-based organ-specific aging clock predicts human diseases and mortality
npj Digital Medicine, Published online: 25 February 2026; doi:10.1038/s41746-026-02463-2Considering the missing science of retraining and maintenance in medical artificial intelligence, using ophthalmology as an exemplar
npj Digital Medicine, Published online: 25 February 2026; doi:10.1038/s41746-026-02479-8Effectiveness, acceptability, adherence, and safety of exergaming for depressive symptoms: a systematic review and meta-analysis
The Prostox assay range is designed to encourage informed decision-making when choosing a treatment option in localised prostate cancer. The post MiraDx expands predictive oncology testing arsenal with Prostox Standard appeared first on Medical Device Network.
Smith+Nephew has signed a distribution agreement with SI-BONE for the iFuse TORQ pelvic fracture fixation portfolio. The post Smith+Nephew, SI-BONE partner to distribute iFuse TORQ portfolio appeared first on Medical Device Network.